What is Blueprint's NAICS code?

Blueprint's NAICS code is 23 (Construction).

Blueprint Company Overview, Contact Details & Competitors

Q: What is Blueprint's official website and social media links?

Blueprint's official website is blueprint-robotics.com. Blueprint has social profiles on LinkedIn.

Q: How many employees does Blueprint have currently?

Blueprint has approximately 69 employees.

Q: What technology does Blueprint use?

Blueprint's tech stack includes Microsoft 365, RSS, Webpack, Microsoft, Open Graph.

Insights

Gathering insights about Blueprint…

Similar companies to Blueprint

Blueprint Tech Stack

Blueprint uses 8 technology products and services including Cart Functionality, Squarespace Commerce, Google Fonts API, and more. Explore Blueprint's tech stack below.

Cart Functionality
E-commerce
Squarespace Commerce
E-commerce
Google Fonts API
Font Scripts
Modernizr
Javascript Libraries
Microsoft
Miscellaneous
Python
Programming Languages
Adobe Fonts
Web Fonts
GoDaddy
Web Hosting

Media & News

Shareholder Alert: The Ademi Firm Investigates the Blueprint Medicines Corporation Transaction
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Blueprint (Nasdaq: BPMC) and its transaction with Sanofi. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, Blueprint insiders received substantial benefits as part of change of control arrangements and certain insiders may have had conflicts of interests. We are investigating whe.
Aug 27, 2025 | www.businesswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Blueprint Medicines Corporation (NASDAQ: BPMC)
NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Blueprint Medicines Corporation (NASDAQ: BPMC ) related to its sale to Sanofi, S.A. Under the terms of the proposed transaction, Sanofi will pay $129.00 per share in cash at closing, and Blueprint shareholders also will receive one non-tradeable contingent value right (“CVR”) entitling the holder to receive two potential milestone payments of $2.00 and $4.00 per CVR for the achievement, respectively, of future development and regulatory milestones for BLU-808. Is it a fair deal?
Jul 14, 2025 | www.globenewswire.com
BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Blueprint Medicines Corporation (NasdaqGS: BPMC) to Sanofi (NasdaqGS: SNY). Under the terms of the proposed transaction, shareholders of Blueprint will receive $129.00 per share in cash at closing, and also will receive one non-tradeable contingent value right (CVR) entitling the holder to receive t.
Jun 20, 2025 | www.businesswire.com
HAPPY FATHER'S DAY! and $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Blueprint Medicines Corporation (NASDAQ: BPMC)
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Blueprint Medicines Corporation (NASDAQ: BPMC ) related to it sale to Sanofi. Under the terms of the proposed transaction, Sanofi will pay $129.00 per share in cash at closing, and Blueprint shareholders also will receive one non-tradeable contingent value right (CVR) entitling the holder to receive two potential milestone payments of $2.00 and $4.00 per CVR for the achievement, respectively, of future development and regulatory milestones for BLU-808. Is it a fair deal?
Jun 15, 2025 | www.globenewswire.com
Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI Congresses
-- Breadth of presentations, including one oral and two flash talks, showcase Blueprint Medicines' leadership role in advancing care for patients with systemic mastocytosis -- CAMBRIDGE, Mass. , June 12, 2025 /PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC) today announced data presentations reflecting over a decade of collaboration with clinical experts and patient advocates to transform the treatment of systemic mastocytosis (SM).
Jun 12, 2025 | www.prnewswire.com
BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Blueprint Medicines Corporation (NasdaqGS: BPMC) to Sanofi (NasdaqGS: SNY). Under the terms of the proposed transaction, shareholders of Blueprint will receive $129.00 per share in cash at closing, and also will receive one non-tradeable contingent value right (CVR) entitling the holder to rece.
Jun 03, 2025 | www.businesswire.com
Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz
Jared Holz, Mizuho health care equity strategist, joins 'The Exchange' to discuss the impact of tariffs on pharmaceuticals and how to trade in the sector.
Jun 02, 2025 | www.youtube.com

Blueprint's Email Address Formats

Blueprint uses at least 1 format(s):

Blueprint Email Formats	Example	Percentage
FLast@blueprint-robotics.com	JDoe@blueprint-robotics.com	68%
FL@blueprint-robotics.com	JD@blueprint-robotics.com	23%
LF@blueprint-robotics.com	DJ@blueprint-robotics.com	7%
First@blueprint-robotics.com	John@blueprint-robotics.com	2%

Frequently Asked Questions

Where is Blueprint's headquarters located?

Blueprint's main headquarters is located at 1500 Broening Highway Baltimore, Maryland 21224 United States. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is Blueprint's phone number?

You can contact Blueprint's main corporate office by phone at

+1-443-927-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Blueprint's stock symbol?

Blueprint is a publicly traded company; the company's stock symbol is BPMC.

What is Blueprint's official website and social media links?

Blueprint's official website is blueprint-robotics.com and has social profiles on LinkedIn.

What is Blueprint's SIC code NAICS code?

Blueprint's SIC code is 7334 - Photocopying and Duplicating Services NAICS code is 23 - Construction.

How many employees does Blueprint have currently?

As of March 2026, Blueprint has approximately 69 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Operating Officer: J. B.President Chief Executive Officer: J. C.President Mass Timber Division & Chief Innovation Officer: M. L.. Explore Blueprint's employee directory with LeadIQ.

What industry does Blueprint belong to?

Blueprint operates in the Construction industry.

What technology does Blueprint use?

Blueprint's tech stack includes Cart FunctionalitySquarespace CommerceGoogle Fonts APIModernizrMicrosoftPythonAdobe FontsGoDaddy.

What is Blueprint's email format?

Blueprint's email format typically follows the pattern of FLast@blueprint-robotics.com. Find more Blueprint email formats with LeadIQ.

When was Blueprint founded?

Blueprint was founded in 2015.

Insights

Similar companies to Blueprint

ABB Robotics

Universal Robots

Comau

Kawasaki Robotics

Yaskawa Motoman

Boston Dynamics

Blueprint Tech Stack

Media & News

Shareholder Alert: The Ademi Firm Investigates the Blueprint Medicines Corporation Transaction

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Blueprint Medicines Corporation (NASDAQ: BPMC)

BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC

HAPPY FATHER'S DAY! and $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Blueprint Medicines Corporation (NASDAQ: BPMC)

Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI Congresses

BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC

Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz

Blueprint's Email Address Formats

Frequently Asked Questions

Where is Blueprint's headquarters located?

What is Blueprint's phone number?

What is Blueprint's stock symbol?

What is Blueprint's official website and social media links?

What is Blueprint's SIC code NAICS code?

How many employees does Blueprint have currently?

What industry does Blueprint belong to?

What technology does Blueprint use?

What is Blueprint's email format?

When was Blueprint founded?

Blueprint

Company Overview

Media & News

Shareholder Alert: The Ademi Firm Investigates the Blueprint Medicines Corporation Transaction

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Blueprint Medicines Corporation (NASDAQ: BPMC)

BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?